Edition:
United Kingdom

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

25.51USD
17 Jan 2019
Change (% chg)

-- (--)
Prev Close
$25.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
93,433
52-wk High
$45.61
52-wk Low
$18.56

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $702.77
Shares Outstanding(Mil.): 30.68
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.08 -- --
ROI: -- 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates